Glenmark board approves to sell 75% in Glenmark Life Sciences to Nirma for Rs 5,651.5 crore

Glenmark board approves to sell 75% in Glenmark Life Sciences to Nirma for Rs 5,651.5 crore
Glenmark Pharmaceuticals on Thursday said it will sell a 75 per cent stake, image credit: Unsplash

Glenmark Pharmaceuticals on Thursday said it will sell a 75 per cent stake in its subsidiary Glenmark Life Sciences to Nirma Ltd for Rs 5,651.5 crore.

The company's board at its meeting held on September 21, 2023, considered and approved the sale of 91,895,379 shares representing 75 per cent share capital of Glenmark Life Sciences Ltd to Nirma Ltd at a price of Rs 615 per share, aggregating to Rs 5,651.5 crore, the Mumbai-based drug maker said in a regulatory filing.

As part of the transaction, the company, Glenmark Life Sciences and Nirma have agreed to certain non-compete and non-solicit arrangements for a specified period, it added.

Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.

RECOMMENDED STORIES

https://www.zeebiz.com/personal-finance/photo-gallery-sukanya-samriddhi-yojana-ssy-and-ppf-public-provident-fund-rs-100000-per-year-investment-for-15-years-which-can-create-larger-corpus-on-maturity-calculate-331817

Sukanya Samriddhi Yojana vs PPF: Rs 1 lakh/year investment for 15 years; which can create larger corpus on maturity?

https://www.zeebiz.com/personal-finance/photo-gallery-top-7-flexi-cap-sip-mutual-funds-with-highest-best-xirr-return-in-1-year-calculator-inr-rs-20000-monthly-investment-in-no-1-scheme-has-generated-302-lakh-bse-nifty-500-motilal-bank-hsbc-of-india-aum-nav-333620

Top 7 Flexi Cap Mutual Funds With up to 52% SIP Return in 1 Year: Rs 20,000 monthly SIP investment in No. 1 fund has generated Rs 3.02 lakh; know about others too

https://www.zeebiz.com/personal-finance/photo-gallery-top-7-gold-etfs-with-best-highest-cagr-annual-returns-in-3-years-calculator-no-1-mutual-fund-has-converted-inr-rs-700000-into-1079960-lic-hdfc-uti-invesco-fof-domestic-pure-price-benchmark-333814

Top 7 Gold ETFs With Best Returns in 3 Years: No.1 ETF has converted Rs 7 lakh investment into Rs 10.80 lakh; know how others have fared

https://www.zeebiz.com/personal-finance/photo-gallery-post-office-fd-fixed-deposit-vs-rd-recurring-deposit-which-can-offer-higher-returns-on-rs-1000000-investment-in-5-years-interest-comparison-see-calculations-333662

Post Office FD vs RD: Which can offer higher returns on Rs 10,00,000 investment in 5 years?

https://www.zeebiz.com/personal-finance/photo-gallery-rs-5500000-home-loan-emi-vs-55-lakh-sip-mutual-fund-investment-calculator-which-can-be-faster-route-to-arrange-money-for-6100000-home-interest-rate-repayment-calculations-333443

Rs 55 lakh Home Loan vs Rs 55 lakh SIP investment: Which can be faster route to arrange money for Rs 61 lakh home? Know here

https://www.zeebiz.com/personal-finance/photo-gallery-sip-vs-ppf-public-provident-fund-compare-rs-120000-lakh-per-year-investment-over-15-years-to-determine-which-option-creates-higher-corpus-for-your-financial-goals-333092

SIP vs PPF: Rs 1,20,000 lakh per year investment for 15 years; which can create higher corpus?

Written By: PTI
Updated: Thu, Sep 21, 2023
07:51 PM IST
PTI
RELATED NEWS
Glenmark launches generic glaucoma treatment ophthalmic solution Glenmark launches generic glaucoma treatment ophthalmic solution
Glenmark Pharma gets USFDA nod for seizure treatment drug Glenmark Pharma gets USFDA nod for seizure treatment drug

By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.

x